Desloratadine and loratadine use associated with improved melanoma survival
Ildikó Fritz, Philippe Wagner, Matteo Bottai, Hanna Eriksson, Christian Ingvar, Isabelle Krakowski, K. Nielsen, Håkan Olsson
Abstract
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
DesloratadineLoratadineMedicineMelanomaDermatologyPharmacologyCancer researchMelanoma and MAPK PathwaysCancer Immunotherapy and BiomarkersCancer, Stress, Anesthesia, and Immune Response